LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced the completion of its merger with NOMAD Transportable Power Systems Inc., making NOMAD a wholly owned subsidiary. In connection with the transaction, the company issued 2,992,041 shares of common stock and 50,366.07 shares of newly authorized Series D preferred stock to NOMAD’s accredited stockholders. The company also changed its corporate name to NOMAD Power Solutions Inc., effective July 3, 2026, and will begin trading under the ticker symbol “NMAD” on July 6, 2026.
The merger transforms the company’s business to focus on deployable utility-grade battery energy storage systems, positioning it to address growing demand driven by artificial intelligence, electrification, grid modernization and industrial expansion. NOMAD will continue to operate under CEO John Travaglini, who noted that the business is engaged on more than 30 active utility, infrastructure and strategic customer projects across North America and expects public market access to support continued manufacturing expansion and growth. The full press release is available at https://nnw.fm/hKuCR.
This strategic pivot marks a significant shift from LIXTE’s previous focus on clinical-stage pharmaceutical and med-tech development. LIXTE had been advancing cancer therapies, including its lead compound LB-100, a first-in-class PP2A inhibitor, and through its subsidiary Liora Technologies Europe Ltd., developing proton therapy systems. However, the merger with NOMAD redirects the company’s resources toward the rapidly expanding energy storage market.
The importance of this announcement lies in its implications for the energy sector. As demand for reliable and scalable energy storage solutions grows—fueled by the rise of AI data centers, electrification of transportation, and grid modernization—NOMAD Power Solutions aims to capitalize on these trends. The company’s deployable battery systems can be rapidly deployed to meet peak demand or provide backup power, offering a flexible alternative to traditional infrastructure investments.
For investors, the name change and new ticker symbol signal a fresh start and a focus on a high-growth industry. The merger provides NOMAD with access to public capital markets, which could accelerate its manufacturing expansion and enable it to capture a larger share of the North American energy storage market. The company’s existing portfolio of over 30 active projects suggests a strong pipeline of potential revenue.
However, the transition also carries risks. The company must successfully integrate NOMAD’s operations and execute on its growth strategy while managing competitive pressures from established energy storage players. Additionally, the shift away from biotechnology means that investors who were attracted to LIXTE’s cancer drug development programs will now be exposed to a different set of industry dynamics and risks.
Overall, the completion of the merger and rebranding positions NOMAD Power Solutions to leverage public market support for expansion in the energy storage sector. The company’s ability to deliver on its more than 30 active projects and scale manufacturing will be key to its success. More information about the company can be found at www.lioratechnologies.com, and updates are available in the company’s newsroom at https://nnw.fm/LIXT.
